A blood-based diagnostic kit designed for the rapid and accurate identification of traumatic brain injury using dual biomarker detection with high sensitivity and specificity. The kit detects GFAP and UCH-L1 proteins that leak into bloodstream following head trauma.
Manufactured by
Ezdiatech Inc
South Korea
VEUS, the abbreviation of Versatile, Easy, and User-friendly System, is a diagnostic system: Versatile – almost all in vitro diagnostic items are applicable; Easy – the system entirely automated enabling easy testing with no pretreatment required; User-friendly – anybody can use the system easily. Furthermore, it delivers rapid and accurate results for efficient clinical decision-making.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Lansion Biotechnology Co., Ltd.
China · 7 relevant products
GenSure Biotech Inc.
China · 3 relevant products
Quidel China Ltd.
China · 1 relevant product
63 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 104 closest product alternatives
Lansion Biotechnology Co., Ltd. · China
In vitro diagnostic reagent for neurological injury assessment. Supports rapid detection of brain injury biomarkers.
GenSure Biotech Inc. · China
Diagnostic test kit for measurement of biomarkers associated with cerebrovascular disease and stroke risk. Facilitates assessment of neurological and cerebrovascular health status.
Quidel China Ltd. · China
Cardiac Injury Triple Test Kit using fluorescence immunoassay technology for rapid detection of cardiac biomarkers. Enables simultaneous measurement of multiple cardiac injury markers to support acute coronary syndrome diagnosis and risk stratification in clinical laboratory and point-of-care settings.
101 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products